Published in Intern Emerg Med on October 07, 2012
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One (2013) 6.44
E-cigarettes and smoking cessation: a critique of a New England Journal Medicine-commissioned case study. Intern Emerg Med (2016) 0.76
The management of asthmatic smokers. Asthma Res Pract (2016) 0.75
Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping. Pneumonia (Nathan) (2016) 0.75
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One (2013) 6.44
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health (2011) 5.43
Treatment strategies for allergy and asthma. Nat Rev Immunol (2008) 2.92
Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res (2014) 2.70
The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med (2012) 2.46
The mechanisms, diagnosis, and management of severe asthma in adults. Lancet (2006) 2.40
Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med (2013) 2.03
A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J (2013) 1.93
Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health (2013) 1.93
Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep (2011) 1.89
TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond) (2005) 1.66
A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int (2004) 1.46
Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis (2010) 1.42
Obtaining good quality medical information from the World Wide Web. Ann Ital Med Int (2002) 1.39
Common predictors of smoking cessation in clinical practice. Respir Med (2008) 1.34
Adenosine in the airways: implications and applications. Eur J Pharmacol (2006) 1.29
Time for evidence-based e-cigarette regulation. Lancet Oncol (2013) 1.17
Diesel fumes and the rising prevalence of atopy: an urban legend? Curr Allergy Asthma Rep (2003) 1.14
Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health (2014) 1.14
The Health Effects of Electronic Cigarettes. N Engl J Med (2016) 1.08
Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol (2008) 1.06
Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis. Reprod Biomed Online (2009) 0.99
Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med (2007) 0.97
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr Opin Allergy Clin Immunol (2006) 0.95
Research applications and implications of adenosine in diseased airways. Trends Pharmacol Sci (2003) 0.94
Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome. Chest (2006) 0.94
Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b. Clin Ther (2002) 0.92
Anti-IgE--emerging opportunities for Omalizumab. Expert Opin Biol Ther (2013) 0.92
Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD. Drug Discov Today (2010) 0.90
Therapeutic potential of adenosine receptor antagonists and agonists. Expert Opin Ther Pat (2007) 0.89
Electronic cigarette use and harm reversal: emerging evidence in the lung. BMC Med (2015) 0.89
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest (2010) 0.89
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res (2011) 0.87
Preventing progression of allergic rhinitis to asthma. Curr Allergy Asthma Rep (2014) 0.87
The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol (2004) 0.86
Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis. Cell Transplant (2015) 0.85
Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem (2007) 0.84
Adenosine signaling pathways as potential therapeutic targets in respiratory disease. Expert Opin Ther Targets (2013) 0.84
Smoking cessation: present status and future perspectives. Curr Opin Pharmacol (2012) 0.82
Biologic therapy for atopic asthma and beyond. Curr Opin Allergy Clin Immunol (2013) 0.82
Adenosine signalling in airways. Curr Opin Pharmacol (2006) 0.82
Recurrent Hopkin's syndrome: a case report and review of the literature. J Neurol Sci (2010) 0.82
New and emerging infectious diseases. Allergy Asthma Proc (2007) 0.81
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther (2014) 0.81
Recommendation for optimal management of severe refractory asthma. J Asthma Allergy (2010) 0.81
Commentary on Dawkins et al. (2015): electronic cigarettes - from smoking cessation to smoking sensation and back. Addiction (2015) 0.81
Tobacco use cessation counseling of parents. Curr Opin Pediatr (2008) 0.81
Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbations. Haematologica (2008) 0.80
Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respir Med (2008) 0.80
Off-label use of omalizumab in non-asthma conditions: new opportunities. Expert Rev Respir Med (2009) 0.80
Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma. Expert Opin Biol Ther (2013) 0.78
D-dimer in the diagnostic workup of suspected pulmonary embolism: additional clinical value of pretest probability. Chest (2005) 0.77
"Dangerous relationships": asthma and substance abuse. J Addict Dis (2013) 0.77
The role of adenosine as a novel bronchoprovocant in asthma. Curr Opin Allergy Clin Immunol (2003) 0.77
Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation. J Allergy Clin Immunol (2004) 0.77
Monoclonal antibodies for the treatment of severe asthma. Curr Allergy Asthma Rep (2011) 0.77
Study of infliximab treatment in asthma. Am J Respir Crit Care Med (2007) 0.76
Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol (2002) 0.76
Caring for the smoking asthmatic patient. J Allergy Clin Immunol (2012) 0.76
Urban air pollution at the crossroads of the allergic pandemic. Ann Ital Med Int (2003) 0.76
Can immunotherapy prevent progression to asthma in allergic individuals? J Allergy Clin Immunol (2002) 0.76
Adenosine receptors: promising targets for the development of novel therapeutics and diagnostics for asthma. Fundam Clin Pharmacol (2006) 0.76
Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial. Trials (2014) 0.75
The holistic perspective of chronic obstructive pulmonary disease: doubt some more. Ther Adv Chronic Dis (2010) 0.75
Mast cell degranulation after endobronchial adenosine challenge. J Allergy Clin Immunol (2005) 0.75
Monitoring the adjustment of antiasthma medications with adenosine monophosphate bronchoprovocation. Chest (2004) 0.75
The puzzling relationship between cigarette smoking, reduced respiratory function, and systemic inflammation. Chest (2005) 0.75
Tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 0.75
Commentary on Vangeli et al. (2011): Towards an improved understanding of smoking relapse predictors--recipe for success? Addiction (2011) 0.75
Poor quality of life in young smokers with smoking history of short duration. Chest (2005) 0.75
Adenosine monophosphate challenge and monitoring of airway response to antiinflammatory therapy. Am J Respir Crit Care Med (2002) 0.75
Exercise-induced asthma and plasma adenosine: Is there a causative link? J Allergy Clin Immunol (2002) 0.75
Rapid effect of inhaled fluticasone on airway responsiveness to AMP: research implications. J Allergy Clin Immunol (2003) 0.75
Study of infliximab treatment in smokers with COPD: what next? Am J Respir Crit Care Med (2005) 0.75
[Malignant pleural mesothelioma in housewives in the province of Catania]. Recenti Prog Med (2004) 0.75
Stratified medicine in selecting biologics for the treatment of severe asthma. Curr Opin Allergy Clin Immunol (2011) 0.75
Beclomethasone dipropionate attenuates airways hyperresponsiveness to neurokinin A and histamine in asthma. Respir Med (2005) 0.75
Strategies for partner management when treating sexually transmitted infection. J Midwifery Womens Health (2011) 0.75
[Electronic cigarette: current overview and future perspectives]. Epidemiol Prev (2014) 0.75